SILVERNAIL LAUREN P — SEC Form 4 filings
SEC reporting owner CIK 1225755. 9 Form 4 filings on record with FilingPulse; latest filed 2026-06-22.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-01-30 to 2026-06-22. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 1,000 shares, $31,000 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: purchase of 1,000 shares @ $31.00 ($31,000) in HARROW, INC., filed 2026-05-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| HARROW, INC. (HROW) | Director | 5 | 1 leg · 1,000 sh · $31,000 | — | 4 |
| DYNAVAX TECHNOLOGIES CORP (DVAX) | Director | 3 | — | — | 7 |
| Harpoon Therapeutics, Inc. (HARP) | Director | 1 | — | — | 3 |
Form 4 filings — SILVERNAIL LAUREN P
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-22 | 4 | HARROW, INC. (HROW) | Grant/award (A): 5,248 (derivative) @ $0 | EDGAR |
| 2026-05-19 | 4 | HARROW, INC. (HROW) | Purchase (P): 1,000 @ $31 | EDGAR |
| 2026-02-10 | 4 | DYNAVAX TECHNOLOGIES CORP (DVAX) | Disposition to issuer (D): 10,075 · Disposition to issuer (D): 42,750 (derivative) · Disposition to issuer (D): 7,125 (derivative) | EDGAR |
| 2025-06-24 | 4 | HARROW, INC. (HROW) | Grant/award (A): 7,339 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | DYNAVAX TECHNOLOGIES CORP (DVAX) | Grant/award (A): 1,439 @ $0 · Grant/award (A): 7,125 (derivative) @ $0 | EDGAR |
| 2025-02-05 | 4 | DYNAVAX TECHNOLOGIES CORP (DVAX) | Grant/award (A): 8,636 (derivative) · Grant/award (A): 42,750 (derivative) @ $0 | EDGAR |
| 2024-06-17 | 4 | HARROW, INC. (HROW) | Grant/award (A): 8,347 (derivative) @ $0 | EDGAR |
| 2024-03-11 | 4 | Harpoon Therapeutics, Inc. (HARP) | Disposition to issuer (D): 5,000 · Disposition to issuer (D): 2,033 (derivative) · Disposition to issuer (D): 2,300 (derivative) | EDGAR |
| 2024-01-30 | 4 | HARROW, INC. (HROW) | Grant/award (A): 3,119 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1225755 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →